Tanım

Oligonucleotide synthesis is the chemical process by which nucleotides are specifically linked to form the desired sequenced product. The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence. StratejiHelix'e göre, the global oligonucleotide synthesis market is expected to increase by US$ 4,683.6 sırasında milyon 2022-2028, expanding at a CAGR of 9.7% tahmin dönemi boyunca.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for oligonucleotide synthesis. The global oligonucleotide synthesis market is segmented on the basis of product, başvuru, end user, ve bölge. Ürün bazında, the global oligonucleotide synthesis market is categorized into oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services. The oligonucleotide drugs segment captured the largest share of the market in 2021. On the basis of application, the global oligonucleotide synthesis market has been segmented into diagnostics, therapeutics, research. The research segment held the largest share of the global oligonucleotide synthesis market in 2021 ve tahmin dönemi boyunca payını koruması bekleniyor. By end user, the global oligonucleotide synthesis market has been segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes. İçinde 2021, the academic research institutes segment made up the largest share of revenue generated by the oligonucleotide synthesis market. coğrafi olarak, the global oligonucleotide synthesis market is segmented into North America, Asya Pasifik, Avrupa, Dünyanın Geri Kalanı (ROW). Bunların arasında, North America was accounted for the highest revenue generator in 2021.

The global oligonucleotide synthesis market is highly competitive. The prominent players operating in the global oligonucleotide synthesis market include Agilent Technologies Inc., Biolegio BV, Biolytic Lab Performance Inc., CustomArray Inc., Danaher Corporation, Eurofins Scientific SE, LGC Ltd., Merck KGaA, Microsynth AG, Thermo Fisher Scientific Inc.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the oligonucleotide synthesis market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Ürün: oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services
Başvuru: diagnostics, therapeutics, research
End user: pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes
Bölge: Kuzey Amerika, Asya Pasifik, Avrupa, Dünyanın Geri Kalanı (ROW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global oligonucleotide synthesis market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. Oligonucleotide synthesis market overview
Parça 3. Market breakdown by product
– Oligonucleotide drugs
– Synthesized oligonucleotides
– Reagents
– Equipment
– Hizmetler
Parça 4. Market breakdown by application
– Diagnostics
– Therapeutics
– Research
Parça 5. Market breakdown by end user
– Pharmaceutical & biotechnology companies
– Diagnostic laboratories
– Academic research institutes
Parça 6. Market breakdown by region
– Kuzey Amerika
– Asya Pasifik
– Avrupa
– Dünyanın Geri Kalanı (ROW)
Parça 7. Anahtar şirketler
– Agilent Technologies, A.Ş..
– Biolegio BV
– Biolytic Lab Performance, A.Ş..
– CustomArray, A.Ş..
– Danaher Corporation
– Eurofins Scientific SE
– LGC Ltd.
– Merck KGaA
– Microsynth AG
– Thermo Fisher Scientific Inc.
StratejiHelix Hakkında
Sorumluluk reddi beyanı